American depositary receipts of European stocks were trading 1.81% lower at 1,022.54 on the S&P/BNY Mellon Europe Select ADR Index on Thursday.
In continental Europe, the gainers were led by biopharmaceutical company Grifols (GRFS) and biotech firm BioNTech (BNTX), which rose 4.4% each. They were followed by biotech firm Forward Pharma (FWP) and medical device maker EDAP TMS (EDAP), which were up 0.7% and 0.5%.
The decliners in continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and furniture maker Natuzzi (NTZ), which lost 6.2% and 4.2% respectively. They were followed by software firm SAP (SAP) and semiconductor company STMicroelectronics (STM), which dropped 3.7% and 3.6%.
In the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Verona Pharma (VRNA), which rose 4.4% and 2.5% respectively. They were followed by pharmaceutical company Avadel Pharmaceuticals (AVDL) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were up 2.1% and 1.9%.
The decliners in the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and cruise line operator Carnival Corporation (CUK), which fell 11% and 7% respectively. They were followed by biopharmaceutical company Amarin Corporation (AMRN) and software firm Endava (DAVA), which were down 5.8% and 5.6%.